Product Images Ciclopirox Olamine 0.77% / Clobetasol Propionate 0.05% / Salicylic Acid 3%.

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Ciclopirox Olamine 0.77% / Clobetasol Propionate 0.05% / Salicylic Acid 3%. NDC 72934-7039 by Sincerus Florida, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

ss - 7039 6 end

ss - 7039 6 end

This is a set of directions for using a product that is applied topically, only for external use, as directed by a physician. It advises to wash hands after use, store at room temperature, and includes contact information for reporting adverse reactions, contacting the manufacturer, and the FDA. It is not intended for resale.*

ad - 7039 6 front

ad - 7039 6 front

This is a description of a shampoo with various active ingredients including CLOTRIMAZOLE, CLOBETASOL PROPIONATE, SALICYLIC ACID, and CLOPIROX OLAMINE. The shampoo comes in a 120gm bottle and the product is labeled with a National Drug Code (NDC) of 72934-7039-6.*

ww - 7039 6 middle

ww - 7039 6 middle

This is a description of a medication containing active ingredients such as Ciclopirox Olamine USP and Clobetasol Propionate USP. The medication also contains Salicylic Acid USP and other inactive ingredients such as Propylene Glycol USP, Suspendisse Shampoo, and Zinc Pyrithione 50% Dispersion. It is only available through prescription, and the given lot number is 351037ABCDEFGH@1. The expiration date and manufacturing date are January 1, 1970.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.